Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral antimicrobial treatment versus outpatient parenteral therapy for infective endocarditis
2020-001024-34Phase 4Active
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amoxicillin, cefaclor, ciprofloxacin, clindamycin, dicloxacillin and 7 more in endocarditis (IE) (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Primary composite endpoint. Started Sep 2021; status: active.
02
Drugs
amoxicillincefaclorciprofloxacinclindamycindicloxacillin
03
Conditions
endocarditis (IE)
Beyond the preview
Go deeper on 2020-001024-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001024-34.